156 related articles for article (PubMed ID: 17455873)
1. Effect of symptom-to-treatment interval on prognosis in lung cancer.
Annakkaya AN; Arbak P; Balbay O; Bilgin C; Erbas M; Bulut I
Tumori; 2007; 93(1):61-7. PubMed ID: 17455873
[TBL] [Abstract][Full Text] [Related]
2. Delays during the diagnostic evaluation and treatment of lung cancer.
Chandra S; Mohan A; Guleria R; Singh V; Yadav P
Asian Pac J Cancer Prev; 2009; 10(3):453-6. PubMed ID: 19640190
[TBL] [Abstract][Full Text] [Related]
3. Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer.
Berthelet E; Truong PT; Lesperance M; Lim JT; Wai ES; MacNeil MV; Liu M; Joe H; Olivotto IA
Am J Clin Oncol; 2006 Feb; 29(1):21-6. PubMed ID: 16462498
[TBL] [Abstract][Full Text] [Related]
4. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
5. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and staging of lung cancer].
Serke M; Schönfeld N
Dtsch Med Wochenschr; 2007 May; 132(21):1165-9. PubMed ID: 17506012
[TBL] [Abstract][Full Text] [Related]
7. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
[TBL] [Abstract][Full Text] [Related]
8. Wait times in diagnostic evaluation and treatment for patients with stage III non-small cell lung cancer in British Columbia.
Wai ES; Mackinnon M; Hooker R; Moccia P; Perry KR; Truong PT
Am J Clin Oncol; 2012 Aug; 35(4):373-7. PubMed ID: 21422900
[TBL] [Abstract][Full Text] [Related]
9. Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden.
Tendler S; Grozman V; Lewensohn R; Tsakonas G; Viktorsson K; De Petris L
Lung Cancer; 2018 Jun; 120():75-81. PubMed ID: 29748020
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of lung imaging fluorescence endoscopy for detecting synchronous lung cancer.
van Rens MT; Schramel FM; Elbers JR; Lammers JW
Lung Cancer; 2001 Apr; 32(1):13-8. PubMed ID: 11282424
[TBL] [Abstract][Full Text] [Related]
11. [Current treatment concepts of lung cancer].
Kaiser F; Engelhardt M; Rawluk J; Mertelsmann R; Passlick B; Wäsch R
Dtsch Med Wochenschr; 2011 Sep; 136(38):1901-6. PubMed ID: 21915805
[TBL] [Abstract][Full Text] [Related]
12. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
13. Delays in the diagnosis and treatment of non-small-cell lung cancer.
Sulu E; Tasolar O; Berk Takir H; Yagci Tuncer L; Karakurt Z; Yilmaz A
Tumori; 2011; 97(6):693-7. PubMed ID: 22322833
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of serum tumor markers in patients with lung cancer.
Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM
Respiration; 2002; 69(1):25-9. PubMed ID: 11844959
[TBL] [Abstract][Full Text] [Related]
15. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.
Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Shimokata K; Inoue H; Nukiwa T; Miyaoka E;
J Thorac Oncol; 2008 Jan; 3(1):46-52. PubMed ID: 18166840
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer 7: management of lung cancer in elderly patients.
Booton R; Jones M; Thatcher N
Thorax; 2003 Aug; 58(8):711-20. PubMed ID: 12885992
[No Abstract] [Full Text] [Related]
17. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases.
Radzikowska E; Głaz P; Roszkowski K
Ann Oncol; 2002 Jul; 13(7):1087-93. PubMed ID: 12176788
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological analysis of progression-free survival (PFS) and overall survival (OS) in non-small-cell lung cancer patients in Republic of Macedonia.
Risteski M; Crvenkova S; Atanasov Z; Isjanovska R
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):49-61. PubMed ID: 24566015
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic method for early-stage second primary non-small lung cancer: analysis of a population-based database.
Chen C; Wu Z; Wu Z; Wu C; Wang Q; Zhan T; Dong L; Fang S; Wu M
BMC Cancer; 2021 Jun; 21(1):666. PubMed ID: 34088283
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in the diagnosis and treatment of lung cancer.
Gilligan D
Int J Clin Pract; 1998; 52(5):330-4. PubMed ID: 9796565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
